DYNAVAX Trademark

Trademark Overview


On Monday, July 25, 2022, a trademark application was filed for DYNAVAX with the United States Patent and Trademark Office. The USPTO has given the DYNAVAX trademark a serial number of 97518585. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, June 26, 2024. This trademark is owned by Dynavax Technologies Corporation. The DYNAVAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical, scientific, pharmaceutical, and biological research and product development consultation; medical, scientific, pharmaceutical, and biological research and product development for others; medical, scientific, pharmaceutical, biological, vaccine, and vaccine adjuvant research and development; medical testing, namely, providing medical testing services in the field of immunopharmaceuticals, vaccines and vaccine adjuvants and in the field of research relating to hepatitis, viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; testing for scientific research purposes, namely, pharmaceutical testing services
dynavax

General Information


Serial Number97518585
Word MarkDYNAVAX
Filing DateMonday, July 25, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, June 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements


Description of MarkThe mark consists of the word "DYNAVAX" in stylized lettering.
Pseudo MarkDYNA VACCINE; DYNAMIC VACCINE
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical, scientific, pharmaceutical, and biological research and product development consultation; medical, scientific, pharmaceutical, and biological research and product development for others; medical, scientific, pharmaceutical, biological, vaccine, and vaccine adjuvant research and development; medical testing, namely, providing medical testing services in the field of immunopharmaceuticals, vaccines and vaccine adjuvants and in the field of research relating to hepatitis, viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; testing for scientific research purposes, namely, pharmaceutical testing services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 16, 2022
Primary Code042
First Use Anywhere DateSunday, November 30, 2014
First Use In Commerce DateMonday, January 12, 2015

Trademark Owner History


Party NameDynavax Technologies Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Party NameDynavax Technologies Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events


Event DateEvent Description
Thursday, July 28, 2022NEW APPLICATION ENTERED
Tuesday, August 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 10, 2023ASSIGNED TO EXAMINER
Wednesday, May 17, 2023NON-FINAL ACTION WRITTEN
Wednesday, May 17, 2023NON-FINAL ACTION E-MAILED
Wednesday, May 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 2, 2024USE AMENDMENT FILED
Friday, February 2, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, February 24, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 27, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 24, 2024NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, May 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 26, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 26, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED